Form 4: Tesla Director Robyn Denholm Executes Option, Sells Shares Under 10b5-1 Plan
Form 4 Filing
Tesla director Robyn Denholm exercised stock options and sold shares of Tesla common stock on February 3, 2025, according to a pre-arranged Rule 10b5-1 trading plan.
Summary
- On February 3, 2025, Robyn Denholm, a director at Tesla, Inc., executed a non-qualified stock option to acquire 112,390 shares of common stock at a price of $24.73 per share.
- Simultaneously, Denholm sold a total of 112,390 shares of Tesla common stock at prices ranging from $375.062 to $389.08 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on July 25, 2024, for the orderly liquidation of options expiring in 2025.
- Following these transactions, Denholm directly owns 85,000 shares of Tesla common stock and 412,830 derivative securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The filing simply reports transactions under a pre-existing plan, which doesn't inherently indicate positive or negative sentiment about the company's future prospects.
Positives
- The sales were conducted under a pre-arranged 10b5-1 trading plan, which is generally viewed as a transparent and orderly way to liquidate holdings.
- The exercise of options demonstrates confidence in the company, even if followed by a sale.
Negatives
- The sale of a significant number of shares by a director could be perceived negatively by some investors, although it's part of a pre-planned strategy.
Risks
- While the 10b5-1 plan provides a framework, large sales by insiders can sometimes create short-term price pressure on the stock.
- Market sentiment could be affected by the perception of insider selling, even if pre-planned.
Future Outlook
The document does not contain specific forward-looking statements, but it indicates that Robyn Denholm will continue to execute sales under the existing 10b5-1 trading plan until her options expiring in June 2025 are liquidated.
Industry Context
Insider transactions are a common occurrence in publicly traded companies, and the use of 10b5-1 plans is a standard practice to avoid accusations of illegal insider trading. Investors often monitor these filings to gauge sentiment and potential future stock movements.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among executives and directors at publicly traded companies, including Tesla's peers like Apple, Google (Alphabet), and Amazon.
- The volume of shares sold is not unusual for a director exercising and liquidating stock options, and the price range achieved is within the typical market fluctuations for a company like Tesla.
- Similar filings can be observed for directors at other automotive companies like General Motors and Ford, as well as technology companies, reflecting the standard practice of equity compensation and subsequent sales.
Stakeholder Impact
- The transactions could have a minor impact on shareholders due to the potential for short-term price fluctuations.
- The impact on employees, customers, suppliers, and creditors is likely to be negligible.
Next Steps
- Robyn Denholm may continue to execute sales under the Rule 10b5-1 trading plan.
- Investors will likely monitor future Form 4 filings to track further transactions by Denholm and other Tesla insiders.
Key Dates
| Date | Description |
|---|---|
| 2018-06-18 | Start date for monthly vesting of stock options. |
| 2021-06-18 | Date when all options subject to the award became fully vested and exercisable. |
| 2024-07-25 | Date of adoption of the Rule 10b5-1 trading plan. |
| 2025-02-03 | Date of the reported transactions (option exercise and share sales). |
| 2025-02-05 | Date of the Form 4 filing. |
| 2025-06-18 | Expiration date of the stock options. |
Keywords
Tesla, Robyn Denholm, insider trading, Form 4, stock options, Rule 10b5-1, share sale, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.